Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report 2016

Publisher Name :
Date: 09-Dec-2016
No. of pages: 113
Inquire Before Buying

Notes:

Sales, means the sales volume of Non-steroidal Anti-inflammatory Drugs (NSAID)

Revenue, means the sales value of Non-steroidal Anti-inflammatory Drugs (NSAID)

This report studies sales (consumption) of Non-steroidal Anti-inflammatory Drugs (NSAID) in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Bayer (DE)

- Novacap (FR)

- Abbott

- Pfizer Inc

- Geri-Care Pharmaceuticals

- Perrigo Company

- Kopran Ltd.

- Merck Sharp & Dohme Corp.

- Sun Pharmaceutical Industries Ltd

- GlaxoSmithKline

- Reddy Pharmaceuticals Ltd

- Johnson & Johnson

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Non-steroidal Anti-inflammatory Drugs (NSAID) in these regions, from 2011 to 2021 (forecast), like

- United States

- China

- Europe

- Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Aspirin

- Ibuprofen

- Naproxen

- Nabumetone

- Others

Split by applications, this report focuses on sales, market share and growth rate of Non-steroidal Anti-inflammatory Drugs (NSAID) in each application, can be divided into

- Back pain treatment

- Osteoarthritis treatment

- Other disease treatment

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report 2016

Table of Contents
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report 2016
1 Non-steroidal Anti-inflammatory Drugs (NSAID) Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2.1 Aspirin
1.2.2 Ibuprofen
1.2.3 Naproxen
1.2.4 Nabumetone
1.2.5 Others
1.3 Application of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.3.1 Back pain treatment
1.3.2 Osteoarthritis treatment
1.3.3 Other disease treatment
1.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Non-steroidal Anti-inflammatory Drugs (NSAID) (2011-2021)
1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2021)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Competition by Manufacturers, Type and Application
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers
2.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Share by Manufacturers (2011-2016)
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume and Value) by Type
2.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2011-2016)
2.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2011-2016)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume and Value) by Regions
2.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Regions (2011-2016)
2.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Regions (2011-2016)
2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume) by Application
3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume, Value and Sales Price)
3.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2011-2016)
3.1.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2016)
3.1.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2016)
3.1.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2011-2016)
3.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
3.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
3.4 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application
4 China Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume, Value and Sales Price)
4.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2011-2016)
4.1.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2016)
4.1.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2016)
4.1.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2011-2016)
4.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
4.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
4.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application
5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume, Value and Sales Price)
5.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2011-2016)
5.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2016)
5.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2016)
5.1.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2011-2016)
5.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
5.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
5.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application
6 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume, Value and Sales Price)
6.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2011-2016)
6.1.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2016)
6.1.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2016)
6.1.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2011-2016)
6.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
6.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application
7 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Analysis
7.1 Bayer (DE)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.1.4 Main Business/Business Overview
7.2 Novacap (FR)
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 113 Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.2.4 Main Business/Business Overview
7.3 Abbott
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 133 Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.3.4 Main Business/Business Overview
7.4 Pfizer Inc
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Dec Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.4.4 Main Business/Business Overview
7.5 Geri-Care Pharmaceuticals
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.5.4 Main Business/Business Overview
7.6 Perrigo Company
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Million USD Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.6.4 Main Business/Business Overview
7.7 Kopran Ltd.
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Pharmaceuticals Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.7.4 Main Business/Business Overview
7.8 Merck Sharp & Dohme Corp.
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.8.4 Main Business/Business Overview
7.9 Sun Pharmaceutical Industries Ltd
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.9.4 Main Business/Business Overview
7.10 GlaxoSmithKline
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
7.10.4 Main Business/Business Overview
7.11 Reddy Pharmaceuticals Ltd
7.12 Johnson & Johnson
8 Non-steroidal Anti-inflammatory Drugs (NSAID) Maufacturing Cost Analysis
8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast (2016-2021)
12.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue Forecast (2016-2021)
12.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Regions (2016-2021)
12.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2016-2021)
12.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2016-2021)
13 Appendix
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type in 2015
Figure Aspirin Picture
Figure Ibuprofen Picture
Figure Naproxen Picture
Figure Nabumetone Picture
Figure Others Picture
Table Applications of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application in 2015
Figure Back pain treatment Examples
Figure Osteoarthritis treatment Examples
Figure Other disease treatment Examples
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2021)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales of Key Manufacturers (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers (2011-2016)
Figure 2015 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers
Figure 2016 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers
Table 2016 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2011-2016)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2011-2016)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Type (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2011-2016)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate by Type (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Regions (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Regions (2011-2016)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Regions (2011-2016)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Regions (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Regions (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Regions (2011-2016)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate by Regions (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application (2011-2016)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2011-2016)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2011-2016)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Application (2011-2016)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2016)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2016)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2011-2016)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2011-2016)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Manufacturers (2011-2016)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2011-2016)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type (2011-2016)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2011-2016)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application (2011-2016)
Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2016)
Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2016)
Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2011-2016)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2011-2016)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Manufacturers (2011-2016)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2011-2016)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type (2011-2016)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2011-2016)
Table China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application (2011-2016)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2016)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2016)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2011-2016)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2011-2016)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Manufacturers (2011-2016)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2011-2016)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type (2011-2016)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2011-2016)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application (2011-2016)
Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2016)
Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2016)
Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2011-2016)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2011-2016)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Manufacturers (2011-2016)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2011-2016)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type (2011-2016)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2011-2016)
Table Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application (2011-2016)
Table Bayer (DE) Basic Information List
Table Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Novacap (FR) Basic Information List
Table Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Abbott Basic Information List
Table Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Geri-Care Pharmaceuticals Basic Information List
Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Perrigo Company Basic Information List
Table Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Kopran Ltd. Basic Information List
Table Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Merck Sharp & Dohme Corp. Basic Information List
Table Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Sun Pharmaceutical Industries Ltd Basic Information List
Table Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Reddy Pharmaceuticals Ltd Basic Information List
Table Reddy Pharmaceuticals Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Reddy Pharmaceuticals Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Non-steroidal Anti-inflammatory Drugs (NSAID) Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
Table Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2015
Table Major Buyers of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table Distributors/Traders List
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate Forecast (2016-2021)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate Forecast (2016-2021)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Regions (2016-2021)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2016-2021)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2016-2021)
  • Global Ibuprofen Market Insights and Forecast to 2027
    Published: 06-May-2021        Price: US 4900 Onwards        Pages: 110
    Ibuprofen market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - USP - EP Segment by Application - Tablet - Capsule - Suspension - Others......
  • 2020-2025 Global Methylprednisolone Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 29-Apr-2021        Price: US 3360 Onwards        Pages: 100
    This report elaborates the market size, market characteristics, and market growth of the Methylprednisolone industry, and breaks down according to the type, application, and consumption area of Methylprednisolone. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and i......
  • Global Celecoxib Sales Market Report 2021
    Published: 29-Apr-2021        Price: US 4000 Onwards        Pages: 134
    The global Celecoxib market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Celecoxib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 50mg - 100mg - 200mg - 400mg ......
  • Global Mesalazine Sales Market Report 2021
    Published: 22-Apr-2021        Price: US 4000 Onwards        Pages: 149
    The global Mesalazine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mesalazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Purity ? 97 % - Purity ? 98 % - Purity ? 99 %......
  • Global Diclofenac Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 12-Apr-2021        Price: US 2980 Onwards        Pages: 76
    Snapshot The global Diclofenac market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Diclofenac by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besid......
  • Global Celecoxib Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 10-Apr-2021        Price: US 2980 Onwards        Pages: 93
    Snapshot The global Celecoxib market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Celecoxib by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides......
  • Investigation Report on Chinese Adalimumab Market, 2021-2025
    Published: 09-Apr-2021        Price: US 2600 Onwards        Pages: 40
    In 2010, Adalimumab entered the Chinese market. Its original drug is produced by AbbVie Inc., under the brand name HUMIRA. The sales of HUMIRA is ranking at Top one among all pharmaceutical products since it is used for a huge amount of disease treatments (such as treatment of arthritis, Crohn's disease, ulcerative colitis, and so on). However, unlike the EU and the NA market, Adalimumab is not popular in the Chinese market. From 2016 to 2019, the sales of Adalimumab decreased gradually due to t......
  • Global Methylprednisolone Sales Market Report 2021
    Published: 08-Apr-2021        Price: US 4000 Onwards        Pages: 124
    The global Methylprednisolone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Methylprednisolone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Infusion Type - Oral Type ......
  • 2020-2025 Global Antibacterial Drugs Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 08-Apr-2021        Price: US 3360 Onwards        Pages: 130
    This report elaborates the market size, market characteristics, and market growth of the Antibacterial Drugs industry, and breaks down according to the type, application, and consumption area of Antibacterial Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sal[email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs